Literature DB >> 20357475

Correlation between first-trimester maternal serum markers, second-trimester uterine artery doppler indices and pregnancy outcome.

Banu Dane1, Cem Dane, Murat Kiray, Ahmet Cetin, Macit Koldas, Murat Erginbas.   

Abstract

AIMS: The aim of this study was to assess the correlation between first trimester maternal serum free beta-human chorionic gonadotropin (fBHCG), pregnancy-associated plasma protein A (PAPPA), second-trimester uterine artery (UA) Doppler measurements and adverse pregnancy outcomes.
METHODS: Serum levels of PAPPA and fBHCG were determined at the first trimester, and patients underwent bilateral UA Doppler assessments at 20-25 weeks of gestation. A serum PAPPA level <0.4 MoM was termed as low and the abnormal Doppler findings were the presence of bilateral notches and RI >0.52 (mean) or unilateral notch and RI >0.66 (90th percentile).
RESULTS: Mean PAPPA level was significantly lower in cases with unilateral or bilateral notches (1.09; 0.79 and 0.80 MoM for 0, 1 and 2 notches, p < 0.001). Fifty-two cases (12.8%) had a low PAPPA level; in this group the incidence of abnormal Doppler was significantly higher (34.6 vs. 18.4%, p = 0.011). In the presence of abnormal Doppler in a case with a low serum PAPPA the risk of pregnancy-induced hypertension (OR = 4.56, p = 0.0067), low birth weight (OR = 6.8, p = 0.0002) and the risk of at least one complication (OR = 7.6, p = 0.00001) were significantly high.
CONCLUSION: Combination of first- and second-trimester findings might improve the efficiency of screening for pregnancy complications. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357475     DOI: 10.1159/000303260

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Predictive values of maternal serum PAPP-A level, uterine artery Doppler velocimetry, and fetal biometric measurements for poor pregnancy and poor neonatal outcomes in pregnant women.

Authors:  Serdar Balcı
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

2.  Association of the very early rise of human chorionic gonadotropin with adverse outcomes in singleton pregnancies after in vitro fertilization.

Authors:  Christopher B Morse; Kurt T Barnhart; Suneeta Senapati; Mary D Sammel; Erica C Prochaska; Anuja Dokras; Charalampos Chatzicharalampous; Christos Coutifaris
Journal:  Fertil Steril       Date:  2016-01-23       Impact factor: 7.329

3.  First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth.

Authors:  M J Stout; K R Goetzinger; M G Tuuli; A G Cahill; G A Macones; A O Odibo
Journal:  Placenta       Date:  2012-11-28       Impact factor: 3.481

Review 4.  Early onset fetal growth restriction.

Authors:  Andrea Dall'Asta; Valentina Brunelli; Federico Prefumo; Tiziana Frusca; Christoph C Lees
Journal:  Matern Health Neonatol Perinatol       Date:  2017-01-18

5.  Association of Early Beta Human Chorionic Gonadotropin With Ischemic Placental Disease in Singleton Pregnancies After In Vitro Fertilization.

Authors:  Jaimin S Shah; Anna M Modest; Michele R Hacker; Nina Resetkova; Laura E Dodge
Journal:  Cureus       Date:  2022-08-17

6.  Diagnostic Value of IGFBP-2 in Predicting Preeclampsia before 20 Weeks of Pregnancy: A Prospective Nested Case-Control Study.

Authors:  Fei Gao; Jiaye Yin; Yan Long; Sufei Zhu; Zhenting Huang; Jielin Wang; Hao Zheng; Wen Wang; Lei Zheng
Journal:  Comput Math Methods Med       Date:  2022-09-28       Impact factor: 2.809

Review 7.  Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis.

Authors:  Yan Zhong; Fufan Zhu; Yiling Ding
Journal:  BMC Pregnancy Childbirth       Date:  2015-08-25       Impact factor: 3.007

8.  Evaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia.

Authors:  Mihaela Daniela Oancea; Nicolae Costin; Daria Maria Pop; Razvan Ciortea; Dan Mihu
Journal:  Clujul Med       Date:  2013-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.